Cenra

Cenra FCF Margin

The Free Cash Flow Margin of Cenra (3716.TW) as of Oct 21, 2026 is 6.17 %. In the previous year, Free Cash Flow Margin was 4.84 % — a change of 27.52% (higher).

FCF Margin

6.17 %

YoY

27.52%

Last updated:

Free Cash Flow Margin of Cenra is 2025 6.17 % . Free Cash Flow Margin of Cenra was 2024 4.84 % . It decreases by 27.52% higher compared to the previous year.

The Cenra FCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Margin
Date
FCF Margin
Jan 1, 2018
-0.72 TWD
Jan 1, 2019
-2.04 TWD
Jan 1, 2020
7.77 TWD
Jan 1, 2021
6.13 TWD
Jan 1, 2022
-1.23 TWD
Jan 1, 2023
3.96 TWD
Jan 1, 2024
4.84 TWD
Jan 1, 2025
6.17 TWD
The Cenra FCF Margin history
YEARFCF MarginYoY
6.17 %+27.52%
4.84 %+22.11%
3.96 %-423.14%
-1.23 %-119.99%
6.13 %-21.04%
7.77 %-481.45%
-2.04 %+181.75%
-0.72 %-113.76%
5.25 %+570.20%
0.78 %-82.07%
4.37 %+460.88%
0.78 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cenra Stock analysis

What does Cenra do? Cenra Inc generates revenue through its subsidiaries that develop, manufacture, and sell pharmaceuticals, agricultural and livestock drugs, personal hygiene, and health products. The company offers human medicines including prescription, over-the-counter, and disease treatment products, medical equipment such as blood pressure monitors and blood glucose meters, animal medicines and feed additives, and daily necessities like oral hygiene products, hand sanitizers, and skin care items. These products are sold under the company's own brand portfolio, targeting consumers, healthcare providers, and veterinary markets. The company's business model focuses on integrated product development and distribution across multiple health and wellness segments. Cenra Inc's product segments include human pharmaceuticals, medical devices, animal health solutions, and personal care items. The human medicine segment covers prescription and over-the-counter drugs, while medical devices include blood pressure monitors and artificial joints. Animal health products consist of medicines, supplementary feeds, and feed additives for disease prevention and nutrition. Personal care products range from oral hygiene to skin care, targeting individual consumers seeking health and wellness solutions. The company's revenue streams are derived from direct sales of these diverse product categories to end-users and healthcare institutions. The company's subsidiaries handle the full value chain from development to sales, ensuring control over product quality and market positioning. By offering a comprehensive range of health-related products, Cenra Inc serves multiple customer segments including individual consumers for personal care, hospitals and clinics for medical equipment, and veterinary clinics for animal health products. This diversified approach allows the company to leverage cross-selling opportunities and maintain steady revenue streams across different market segments. Cenra is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cenra stock

Free Cash Flow Margin of Cenra is 6.17 % in 2025.

Free Cash Flow Margin of Cenra changed from 4.84 % to 6.17 %, representing a 27.52% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Margin Cenra since 2006 – with annual values, charts, and detailed analysis.

FCF Margin measures the percentage of revenue converted to free cash flow. It indicates how efficiently a company generates cash from its operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Margin's Cenra with sector peers and the industry average to assess whether it is attractive.

To evaluate Free Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Cenra

All Key Metrics — Cenra